The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The bmi-1 gene was first isolated as an oncogene that cooperates with c-myc in the generation of mouse lymphomas. We subsequently identified Bmi-1 as a transcriptional repressor belonging to the mouse Polycomb group. The Polycomb group comprises an important, conserved set of proteins that are required to maintain stable repression of specific target genes, such as homeobox-cluster genes, during development. In mice, the absence of bmi-1 expression results in neurological defects and severe proliferative defects in lymphoid cells, whereas bmi-1 overexpression induces lymphomas. Here we show that bmi-1-deficient primary mouse embryonic fibroblasts are impaired in progression into the S phase of the cell cycle and undergo premature senescence. In these fibroblasts and in bmi-1-deficient lymphocytes, the expression of the tumour suppressors p16 and p19Arf, which are encoded by ink4a, is raised markedly. Conversely, overexpression of bmi-1 allows fibroblast immortalization, downregulates expression of p16 and p19Arf and, in combination with H-ras, leads to neoplastic transformation. Removal of ink4a dramatically reduces the lymphoid and neurological defects seen in bmi-1-deficient mice, indicating that ink4a is a critical in vivo target for Bmi-1. Our results connect transcriptional repression by Polycomb-group proteins with cell-cycle control and senescence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although specific mechanisms are as yet unknown, the senescence response appears to result in a reorganization of chromatin, at least some aspects of which require pRB activity (Jacobs et al., 1999; Leung et al., 2001; Bandyopadhyay et al., 2002; Itahana et al., 2003; Narita et al., 2003; Zhang et al., 2003, 2005).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Jacobs et al., 1999
In the citing paper
“Therefore, p16INK4A mediated senescence can be induced via disruption of PRC1/PRC2 complex components such as CBX7, BMI1 or EZH2 followed by decrease in levels of H3K27me3 (Jacobs et al., 1999; Bracken et al., 2003, 2007; Gil et al., 2004).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Jacobs et al., 1999
In the citing paper
“The molecular mechanisms underlying this derepression are not completely understood but have been associated with loss of polycomb group of proteins but independent of p53 (Jacobs et al., 1999; Bracken et al., 2007).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Jacobs et al., 1999
In the citing paper
“Because several studies have established a role for the polycomb group protein Bmi1 in the regulation of p16Ink4a (26–28), we analyzed the levels of Bmi1.”
From Age-Dependent Decline in β-Cell Proliferation Restricts the Capacity of β-Cell Regeneration in Mice (2009) · cites this paper as [27]
In the citing paper
“Overexpression of BMI1 [80], CBX7 [81], or CBX8 [82] results in the direct repression of p16 and senescence delay in human and mouse cells.”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [80]
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Self-citationTumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008
van der Lugt, N. M., Domen, J., Linders, K., van Roon, M., Robanus-Maandag, E., te Riele, H., van der Valk, M., Deschamps, J., Sofroniew, M., & van Lohuizen, M. (1994) · Genes & Development · doi:10.1101/gad.8.7.757 · Cited by 781
Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging
van Lohuizen, M., Verbeek, S., Scheljen, B., Wientjens, E., van der Guidon, H., & Berns, A. (1991) · Cell · doi:10.1016/0092-8674(91)90382-9 · Cited by 762
Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
(1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60352-8 · Cited by 752
Regulation of p16 CDKN2 Expression and Its Implications for Cell Immortalization and Senescence
Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., & Peters, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.859 · Cited by 733
Cited by
Items 301–400 of 1,001
Balasubramanian, S., Adhikary, G., & Eckert, R. L. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp314 · Cited by 142
RetractedTranscriptional repression in eukaryotes: repressors and repression mechanisms
Gaston, K., & Jayaraman, P.-S. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-2260-3 · Cited by 172
Boiko, A. D., Porteous, S., Razorenova, O. V., Krivokrysenko, V. I., Williams, B. R. G., & Gudkov, A. V. (2006) · Genes & Development · doi:10.1101/gad.1372606 · Cited by 152
“The mechanisms of p53 activation by dominant oncogenes, including oncogenic Ras, are relatively well understood and involve transcriptional activation of tumor suppressor ARF detracting Mdm2 from p53 (Kamijo et al. 1997; Jacobs et al. 1999; Inoue et al. 2000).”
BackgroundMohty, M., Yong, A. S. M., Szydlo, R. M., Apperley, J. F., & Melo, J. V. (2007) · Blood · doi:10.1182/blood-2006-12-065599 · Cited by 135
Cancer initiation and progression: Involvement of stem cells and the microenvironment
Tysnes, B. B., & BJERKVIG, R. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.01.001 · Cited by 164
CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes
Dik, W. A., Brahim, W., Braun, C., Asnafi, V., Dastugue, N., Bernard, O., van Dongen, J. J. M., Langerak, A. W., Macintyre, E. A., & Delabesse, É. (2005) · Leukemia · doi:10.1038/sj.leu.2403891 · Cited by 162
The PRC1 Polycomb group complex interacts with PLZF/RARA to mediate leukemic transformation
Boukarabila, H., Saurin, A. J., Batsché, E., Mossadegh, N., van Lohuizen, M., Otte, A. P., Pradel, J., Muchardt, C., Sieweke, M., & Duprez, E. (2009) · Genes & Development · doi:10.1101/gad.512009 · Cited by 126
The Chromatin Landscape of Cellular Senescence
Criscione, S. W., Teo, Y. V., & Neretti, N. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.09.005 · Cited by 137
“In proliferative cells, the INK4A locus is kept in a polycomb repressed state by polycomb repressive complexes (PRC1 and PRC2) first identified by PRC-group protein BMI1 binding to the INK4A locus [65, 66] (Figure 2a).”
BackgroundBMI1 as a novel target for drug discovery in cancer
Cao, L., Bombard, J., Cintron, K., Sheedy, J., Weetall, M. L., & Davis, T. W. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23234 · Cited by 144
“This role in lymphomagenesis has been attributed, in part, to transcriptional repression of the INK4A locus (containing both the p16INK4A and p14ARF genes), leading to maintenance of proliferation and prevention of differentiation [Jacobs et al., 1999b; Itahana et al., 2003].”
BackgroundTargeting Cardiac Stem Cell Senescence to Treat Cardiac Aging and Disease
Cianflone, E., Torella, M., Biamonte, F., De Angelis, A., Urbanek, K., Costanzo, F. S., Rota, M., Ellison-Hughes, G. M., & Torella, D. (2020) · Cells · doi:10.3390/cells9061558 · Cited by 132
“The over-expression of Bmi-1 in mouse embryonic fibroblasts significantly decreases the expression levels of p16INK4a and p19ARF, and it bypasses replicative senescence promoting cell immortalization [86,87].”
BackgroundMalliri, A., van Es, S., Huveneers, S., & Collard, J. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401192200 · Cited by 135
A central role for canonical PRC1 in shaping the 3D nuclear landscape
Boyle, S., Flyamer, I. M., Williamson, I., Sengupta, D., Bickmore, W. A., & Illingworth, R. S. (2020) · Genes & Development · doi:10.1101/gad.336487.120 · Cited by 131
“The polycomb system promotes cell proliferation, in part, by negatively regulating inhibitors of the cell cycle (Jacobs et al. 1999; Gil et al. 2004; Bracken et al. 2007; Chen et al. 2009).”
BackgroundOpposing roles of polycomb repressive complexes in hematopoietic stem and progenitor cells
Majewski, I. J., Ritchie, M. E., Phipson, B., Corbin, J., Pakusch, M., Ebert, A., Busslinger, M., Koseki, H., Hu, Y., Smyth, G. K., et al. (2010) · Blood · doi:10.1182/blood-2009-12-260760 · Cited by 135
Polycomb Repressive Complex 2 (PRC2) Restricts Hematopoietic Stem Cell Activity
Majewski, I. J., Blewitt, M. E., de Graaf, C. A., McManus, E. J., Bahlo, M., Hilton, A. A., Hyland, C. D., Smyth, G. K., Corbin, J. E., Metcalf, D., et al. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060093 · Cited by 131
“(HSCs) [28–30] that mediates its effect in part through control of the Ink4a-Arf locus [29,31,32].”
BackgroundBmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells
Yang, J., Chai, L., Liu, F., Fink, L. M., Lin, P., Silberstein, L. E., Amin, H. M., Ward, D. C., & Ma, Y. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704001104 · Cited by 134
Genomic insights into cancer-associated aberrant CpG island hypermethylation
Sproul, D., & Meehan, R. R. (2013) · Briefings in Functional Genomics · doi:10.1093/bfgp/els063 · Cited by 160
“repressive complexes (PRCs) [101, 102] which have”
Usp16 contributes to somatic stem-cell defects in Down’s syndrome
Adorno, M., Sikandar, S., Mitra, S. S., Kuo, A., Nicolis di Robilant, B., Haro-Acosta, V., Ouadah, Y., Quarta, M., Rodriguez, J., Qian, D., et al. (2013) · Nature · doi:10.1038/nature12530 · Cited by 134
Chromatin silencing and activation by Polycomb and trithorax group proteins
Mahmoudi, T., & Verrijzer, C. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204330 · Cited by 154
“Recently, it has been shown that Bmi-1 controls cell proliferation and senescence through down regulation of the tumor suppressors p16 and p19Arf, encoded by the ink4a locus (Jacobs et al., 1999).”
BackgroundEmerging roles for Polycomb proteins in cancer
Pasini, D., & Di Croce, L. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.03.013 · Cited by 133
PARDAL, R., MOLOFSKY, A. V., HE, S., & MORRISON, S. J. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.057 · Cited by 131
“Deletion of Ink4aArf rescues the ability of Bmi-1–/– mouse embryonic fibroblasts to proliferate in culture and partially rescues cerebellum development in Bmi-1–/– mice (Jacobs et al. 1999a).”
BackgroundSALL4 is a key regulator of survival and apoptosis in human leukemic cells
Yang, J., Chai, L., Gao, C., Fowles, T. C., Alipio, Z., Dang, H., Xu, D., Fink, L. M., Ward, D. C., & Ma, Y. (2008) · Blood · doi:10.1182/blood-2007-11-126326 · Cited by 132
Hoang, D. T., Iczkowski, K. A., Kilari, D., See, W. A., & Nevalainen, M. T. (2016) · Oncotarget · doi:10.18632/oncotarget.12554 · Cited by 142
“com/oncotarget Complex 1 (PRC1), which overrides cellular senescence and promotes self-renewal [202-204].”
BackgroundBmi-1: At the crossroads of physiological and pathological biology
Bhattacharya, R., Mustafi, S. B., Street, M., Dey, A., & Dwivedi, S. K. D. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2015.04.001 · Cited by 143
“p19 induces p53 and causes cell cycle arrest.(51,64) Bmi-1 promotes cell proliferation by suppressing p16/Rb and/or p14/MDM2/p53 tumor suppressor pathways.”
BackgroundInfluentialMihara, K., Chowdhury, M., Nakaju, N., Hidani, S., Ihara, A., Hyodo, H., Yasunaga, S., Takihara, Y., & Kimura, A. (2006) · Blood · doi:10.1182/blood-2005-06-2393 · Cited by 130
Kohlhammer, H., Schwäenen, C., Weßendorf, S., Holzmann, K., Kestler, H. A., Kienle, D., Barth, T. F. E., Möller, P., Ott, G., Kalla, J., et al. (2004) · Blood · doi:10.1182/blood-2003-12-4175 · Cited by 132
Emerging Roles for Polycomb-Group Proteins in Stem Cells and Cancer
Chan, H. L., & Morey, L. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2019.04.005 · Cited by 138
Wong, E. S. M., Guezennec, X. L., Demidov, O. N., Marshall, N. T., Wang, S. T., Krishnamurthy, J., Sharpless, N. E., Dunn, N. R., & Bulavin, D. V. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.05.009 · Cited by 141
Miao, D., Su, H., He, B., Jianjun, G., Xia, Q., Zhu, M., Gu, Z., Goltzman, D., & Karaplis, A. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805690105 · Cited by 132
“Cell-cycle progression PTHrP (1-139) PTHrP (1-84)”
BackgroundInfluentialNdy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a / Arf locus
Tzatsos, A., Pfau, R., Kampranis, S. C., & Tsichlis, P. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813139106 · Cited by 126
“To address whether Ndy1 protects cells from oncogene-induced senescence, we expressed RasV12 in MEFs either alone or in combination with Ndy1 or Bmi1, a known inhibitor of oncogene-induced senescence (6, 36).”
Polyhomeotic has a tumor suppressor activity mediated by repression of Notch signaling
Martinez, A., Schuettengruber, B., Sakr, S., Janic, A., González, C., & Cavalli, G. (2009) · Nature Genetics · doi:10.1038/ng.414 · Cited by 140
BMI-1 Promotes Ewing Sarcoma Tumorigenicity Independent of CDKN2A Repression
Douglas, D., Hsu, J. H.-R., Hung, L., Cooper, A., Abdueva, D., van Doorninck, J., Peng, G., Shimada, H., Triche, T. J., & Lawlor, E. R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6152 · Cited by 128
“Mechanistically, BMI-1 maintains stemness and prevents premature cellular senescence in large part through transcriptional repression of Cdkn2a (11).”
Cohen, I., Zhao, D., Bar, C., Valdes, V. J., Dauber-Decker, K. L., Nguyen, M. B., Nakayama, M., Rendl, M., Bickmore, W. A., Koseki, H., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.04.005 · Cited by 124
Chromatin remodeling in development and differentiation
Müller, C., & Leutz, A. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00175-1 · Cited by 151
Stress-induced Premature Senescence (SIPS)
SUZUKI, M., & BOOTHMAN, D. A. (2008) · Journal of Radiation Research · doi:10.1269/jrr.07081 · Cited by 126
PML interaction with p53 and its role in apoptosis and replicative senescence
Pearson, M. A., & Pelicci, P. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204856 · Cited by 143
“…senescence in murine ®broblasts as ablation of either protein results in immortalization (Harvey et al., 1993; Kamijo et al., 1997), whereas ®broblasts lacking Bmi-1, a p19ARF transcriptional repressor, underwent premature senescence that was dependent on both p19ARF and p53 (Jacobs et al., 1999).”
BackgroundMallette, F. A., & Richard, S. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.033 · Cited by 120
“The regulation of the ARF locus by the Polycomb group (PcG) protein Bmi-1 allows bypass of senescence by downregulating the expression of INK4A and ARF (Jacobs et al., 1999).”
BackgroundDukers, D. F., van Galen, J. C., Giroth, C., Jansen, P. M., Sewalt, R. G. A. B., Otte, A. P., Kluin‐Nelemans, H. C., Meijer, C. J. L. M., & Raaphorst, F. M. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63175-6 · Cited by 140
“40–42 Various BMI-1 binding partners have also been associated with malignant transformation, but appear to do so by mechanisms that do not involve the p16 pathway.”
BackgroundInfluentialNarayanan, R., Pirouz, M., Kerimoglu, C., Pham, L., Wagener, R. J., Kiszka, K. A., Rosenbusch, J., Seong, R. H., Kessel, M., Fischer, A., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.046 · Cited by 139
“The removal of H3K27me2/3 marks is important for the robust induction of many cell-type-specific genes during differentiation (Burgold et al., 2008; Hirabayashi et al., 2009; Jacobs et al., 1999; Liu et al., 2009; Pereira et al., 2010).”
BackgroundGuo, W.-J., Zeng, M.-S., Yadav, A., Song, L.-B., Guo, B.-H., Band, V., & Dimri, G. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4368 · Cited by 122
Zencak, D. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3452-04.2005 · Cited by 117
“Bmi1 regulates long-term renewal of fibroblasts (Jacobs et al., 1999) and was recently described to be essential for the renewal of adult hematopoietic stem cells (Park et al., 2003).”
BackgroundMethodInfluentialContribution of Polycomb Homologues Bmi-1 and Mel-18 to Medulloblastoma Pathogenesis
Wiederschain, D., Chen, L., Johnson, B. V., Bettano, K. A., Jackson, D., Taraszka, J. A., Wang, Y., Jones, M. D., Morrissey, M., Deeds, J. D., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02244-06 · Cited by 136
“Mel-18 can also suppress p16 expression (21); however, the precise mechanisms of its contribution to stem cell maintenance have not yet been fully defined.”
BackgroundReprogramming fibroblasts into induced pluripotent stem cells with Bmi1
Moon, J.-H., Heo, J. S., Kim, J. S., Jun, E. K., Lee, J. H., Kim, A., Kim, J., Whang, K. Y., Kang, Y., Yeo, S., et al. (2011) · Cell Research · doi:10.1038/cr.2011.107 · Cited by 129
Liu, L., Qiu, M., Tan, G., Liang, Z., Qin, Y., Chen, L., Chen, H., & Liu, J. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0305-z · Cited by 125
“BMI-1 is a PcG protein that has been shown to be an important transcriptional repressor of the Ink4a/Arf gene locus [29-31], which encodes two separate gene products (p16 ink4a and p14 Arf ) from two distinct reading frames.”
BackgroundThe great unravelling: chromatin as a modulator of the aging process
O'Sullivan, R. J., & Karlseder, J. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.08.001 · Cited by 116
“In fact, ectopic over-expression of BMI1 and CBX7 extends the proliferative lifespan of cells in vitro by suppression of p16INK4A [16,17].”
Backgroundvan der Stoop, P., Boutsma, E. A., Hulsman, D., Noback, S., Heimerikx, M., Kerkhoven, R. M., Voncken, J. W., Wessels, L. F. A., & van Lohuizen, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002235 · Cited by 115
“MEFs were isolated from 14.5 day old embryo’s and cultured as described before (Jacobs et al, 1999).”
InfluentialBreuer, R. H. J., Snijders, P. J. F., Smit, E. F., Sutedja, T. G., Sewalt, R. G. A. B., Otte, A. P., van Kemenade, F. J., Postmus, P. E., Meijer, C. J. L. M., & Raaphorst, F. M. (2004) · Neoplasia · doi:10.1593/neo.04160 · Cited by 120
“increased cell proliferation and malignant transformation through suppression of p16 and upregulation of telomerase [28,29,38].”
Palumbo, T., Faucz, F. R., Azevedo, M., Xekouki, P., Iliopoulos, D., & Stratakis, C. A. (2013) · Oncogene · doi:10.1038/onc.2012.190 · Cited by 119
Cellular senescence: Its role in tumor suppression and aging
Ohtani, N., Mann, D. J., & Hara, E. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01123.x · Cited by 114
Cellular senescence: hot or what?
Evan, G. I., & di Fagagna, F. D. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.11.009 · Cited by 140
“confer responsiveness to some oncogenes (Ras [39] and the various E2Fs [40]) have been identified in the ARF promoter and ARF is negatively regulated by a variety of factors such as Bmi-1 [41], Pokemon [42], CBX7 [43], Dmp1 [44] and TBX-3 [45].”
BackgroundKrones-Herzig, A., Adamson, E., & Mercola, D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2628034100 · Cited by 118
Serresi, M., Gargiulo, G., Proost, N., Siteur, B., Cesaroni, M., Koppens, M. A. J., Xie, H., Sutherland, K. D., Hulsman, D., Citterio, E., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.006 · Cited by 128
“In this context, tissue hom inflammatory infiltrates, opening opportunities for exploring P when p53 is intact. opposing oncogene-induced senescence (Bracken et al., 2007; Jacobs et al., 1999).”
BackgroundInfluentialThe emerging role of senescent cells in tissue homeostasis and pathophysiology
Tominaga, K. (2015) · Pathobiology of Aging & Age-related Diseases · doi:10.3402/pba.v5.27743 · Cited by 113
Nacerddine, K., Beaudry, J.-B., Ginjala, V., Westerman, B., Mattiroli, F., Song, J.-Y., van der Poel, H., Ponz, O. B., Pritchard, C., Cornelissen-Steijger, P., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci57477 · Cited by 113
“In addition to its role in cellular transformation, Bmi1 is also a critical regulator of cellular senescence and stem cell self-renewal (31, 32).”
Paranjape, A. N., Andugulapati, S. B., Mandal, T., Krushik, E. V., Nagaraj, P., Mukherjee, G., & Rangarajan, A. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-785 · Cited by 130
“Since then, aberrant overexpression of Bmi1 has been detected in several human cancers including lymphoma, acute myeloid leukemia, colorectal carcinoma, liver carcinoma, non-small cell lung cancer, breast carcinoma, prostate cancer, head and neck squamous cell carcinoma, medulloblastoma, and glioblastoma [14-23].”
BackgroundMolecular pathways and targets in prostate cancer
Shtivelman, E., Beer, T. M., & Evans, C. P. (2014) · Oncotarget · doi:10.18632/oncotarget.2406 · Cited by 127
Role of genetic and epigenetic changes in Burkitt lymphoma
Lindström, M. S., & Wiman, K. G. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00058-5 · Cited by 135
Regulation of ploidy and senescence by the AMPK‐related kinase NUAK1
Humbert, N., Navaratnam, N., Augert, A., Da Costa, M., Martien, S., Wang, J., Martinez, D., Abbadie, C., Carling, D., de Launoit, Y., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.342 · Cited by 115
“…(including the oncoviral proteins E6 and E7) results in bypassed senescence and extension of the replicative life- span of normal human cells (Jacobs et al, 1999; Carnero et al, 2000; Lundberg et al, 2000; Ohtani et al, 2001; Brummelkamp et al, 2002; Shvarts et al, 2002; d’Adda di…”
BackgroundDNMT1 and DNMT3B Modulate Distinct Polycomb-Mediated Histone Modifications in Colon Cancer
Jin, B., Yao, B., Li, J., Fields, C. R., Delmas, A. L., Liu, C., & Robertson, K. D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0116 · Cited by 123
“BMI1 cooperates with MYC to promote lymphomas by repressing the INK4a/ARF tumor suppressor locus (16).”
Regulation of Th2 Cell Differentiation by mel-18, a Mammalian Polycomb Group Gene
Kimura, M. Y., Koseki, Y., Yamashita, M., Watanabe, N., Shimizu, C., Katsumoto, T., Kitamura, T., Taniguchi, M., Koseki, H., & Nakayama, T. (2001) · Immunity · doi:10.1016/s1074-7613(01)00182-0 · Cited by 120
Maintenance of gene expression patterns
Brock, H. W., & Fisher, C. L. (2005) · Developmental Dynamics · doi:10.1002/dvdy.20298 · Cited by 127
“However, it is striking that little is known about MP targets other than homeotic/Hox genes (for exceptions, see Jacobs et al., 1999; Americo et al., 2002; Maurange and Paro, 2002; Bloyer et al., 2003; Chanas et al., 2004; Kirmizis et al., 2004).”
BackgroundPolycomb group protein complexes: do different complexes regulate distinct target genes?
Satijn, D. P. E., & Otte, A. P. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00130-x · Cited by 115
Muñoz-Najar, U., & Sedivy, J. M. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3250 · Cited by 114
“Expression of p16 INK4a and p14 ARF is repressed by H3K27 trimethylation, which serves as a recruitment signal for Polycomb complexes (26, 107, 115). p15 INK4b , on the other hand, is specifically repressed by the histone demethylase Jhdm1b that catalyzes the demethylation of H3K36Me3, a mark…”
Rizo, A., Vellenga, E., de Haan, G., & Schuringa, J. J. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl175 · Cited by 127
“BMI-1 regulates senescence and cell proliferation through p19ARF and p16INK4A (50).”
BackgroundNakamura, T., Blechman, J., Tada, S., Rozovskaia, T., Itoyama, T., Bullrich, F., Mazo, A., Croce, C. M., Geiger, B., & Canaani, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7284 · Cited by 127
Liu, H., Cheng, E. H.-Y., & Hsieh, J. J.-D. (2007) · Genes & Development · doi:10.1101/gad.1574507 · Cited by 113
“Subsequent studies on Bmi-1-associated oncogenesis primarily emphasized the ability of Bmi-1 to suppress the expression of tumor suppressors p16ink4a and ARF, thus promoting caner cell proliferation (Jacobs et al. 1999b).”
BackgroundMouse Models to Disentangle the Hallmarks of Human Aging
Folgueras, A. R., Freitas-Rodríguez, S., Velasco, G., & López-Otín, C. (2018) · Circulation Research · doi:10.1161/circresaha.118.312204 · Cited by 113
“Thus, Bmi1 mice, whose phenotype is mainly driven by the impairment of the self-renewal capacities of different stem cell compartments, showed a significant recovery on mating with mice deficient in the Ink4a/Arf locus.(100,179,180) However, Zmpste24 mice lived longer when removing p53.”
BackgroundEZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis
Wang, C.-G. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i19.2421 · Cited by 114
Long-term maintenance of human hematopoietic stem/progenitor cells by expression of BMI1
Rizo, A., Dontje, B., Vellenga, E., de Haan, G., & Schuringa, J. J. (2008) · Blood · doi:10.1182/blood-2007-08-106666 · Cited by 106
Cancer stem cells and “stemness” genes in neuro-oncology
Nicolis, S. K. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.022 · Cited by 126
Yan, P., Li, Z., Xiong, J., Geng, Z., Wei, W., Zhang, Y., Wu, G., Zhuang, T., Tian, X., Liu, Z., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110038 · Cited by 121
Epigenetic regulation of aging stem cells
Pollina, E. A., & Brunet, A. (2011) · Oncogene · doi:10.1038/onc.2011.45 · Cited by 111
“BMI1 function in young adult HSC and NSC self-renewal is mediated, in large part, through its transcriptional repression of the p16/p19 aging locus (Jacobs et al., 1999).”
BackgroundInfluentialLi, Y., Chen, H., Hardy, T. M., & Tollefsbol, T. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054369 · Cited by 117
“Previous studies also indicated that BMI1 can cooperate with c-MYC to repress p16 expression in the regulation of cellular proliferation during tumorigenesis [39,44].”
BackgroundNovel biological insights in T-cell acute lymphoblastic leukemia
Durinck, K., Goossens, S., Peirs, S., Wallaert, A., Loocke, W. V., Matthijssens, F., Pieters, T., Milani, G., Lammens, T., Rondou, P., et al. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.05.017 · Cited by 123
“In primitive hematopoietic precursor cells, the polycomb repressive complex 2 (PRC2) mediates silencing of the Ink4a-Arf locus [19,20], suggesting that leukemias that originate from hematopoietic progenitors lack the selective pressure for genomic cdkn2a deletion during T-cell transformation [21,22].”
BackgroundBmi1 Enhances Tumorigenicity and Cancer Stem Cell Function in Pancreatic Adenocarcinoma
Proctor, E., Waghray, M., Lee, C. J., Heidt, D. G., Yalamanchili, M., Li, C., Bednar, F., & Simeone, D. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055820 · Cited by 117
“Bmi1 regulates cell cycle progression at least partly by the transcriptional regulation of the Ink4a locus, which contains the p16Ink4a and p14Arf (p16 and p19 in mice) cyclin-dependent kinase inhibitors [4,5].”
BackgroundThe role of Polycomb Group Proteins in Cell Cycle Regulation During Development
Martinez, A., & Cavalli, G. (2006) · Cell Cycle · doi:10.4161/cc.5.11.2781 · Cited by 122
CHMP1A encodes an essential regulator of BMI1-INK4A in cerebellar development
Mochida, G. H., Ganesh, V. S., de Michelena, M. I., Dias, H., Atabay, K. D., Kathrein, K. L., Huang, H.-T., Hill, R. S., Felie, J. M., Rakiec, D., et al. (2012) · Nature Genetics · doi:10.1038/ng.2425 · Cited by 109
p16INK4a and the control of cellular proliferative life span
Huschtscha, L. I. (1999) · Carcinogenesis · doi:10.1093/carcin/20.6.921 · Cited by 111
Tumorigenesis: Twist1 links EMT to self-renewal
Martín, A., & Cano, A. (2010) · Nature Cell Biology · doi:10.1038/ncb1010-924 · Cited by 109
Several Distinct Polycomb Complexes Regulate and Co-Localize on the INK4a Tumor Suppressor Locus
Maertens, G. N., El Messaoudi-Aubert, S., Racek, T., Stock, J. K., Nicholls, J., Rodriguez-Niedenführ, M., Gil, J., & Peters, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006380 · Cited by 106
“consistent with published findings [23,27,28] but our study is the first to compare the different proteins within the same cell system.”
BackgroundResultBeyond transcription factors: how oncogenic signalling reshapes the epigenetic landscape
Liu, F., Wang, L., Perna, F., & Nimer, S. D. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.41 · Cited by 107
The INK4a/ARF locus in murine tumorigenesis
Serrano, M. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.865 · Cited by 108
Sasaki, M., Yamaguchi, J., Itatsu, K., Ikeda, H., & Nakanuma, Y. (2008) · The Journal of Pathology · doi:10.1002/path.2345 · Cited by 106
“EZH2 is the chromatin-modifying enzyme and interacts with the pathways of key elements that control cell growth and proliferation, such as the Rb and p16 INK4a genes [9,11].”
BackgroundFirestein, R., Cui, X., Huie, P., & Cleary, M. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.13.4900-4909.2000 · Cited by 110
“The tumor suppressors p16 and p19, products of the ink4a gene, are critical downstream targets for Bmi-1, an oncoprotein and ortholog of Drosophila Posteriorsex-combs (PSC), a PcG protein (23).”
BackgroundHistone Modifications in Cancer Biology and Prognosis
Kurdistani, S. K. (2010) · Springer eBooks · doi:10.1007/978-3-7643-8989-5_5 · Cited by 121
Consistent expression of the stem cell renewal factor BMI‐1 in primary and metastatic melanoma
Mihic‐Probst, D., Kuster, A., Kilgus, S., Bode‐Lesniewska, B., Ingold‐Heppner, B., Leung, C., Storz, M., Seifert, B., Marino, S., Schraml, P., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22891 · Cited by 107
“showed a downstream effect of BMI-1 on p16.(57)”
BackgroundSelf-citationInoue, K., Zindy, F., Randle, D. H., Rehg, J. E., & Sherr, C. J. (2001) · Genes & Development · doi:10.1101/gad.929901 · Cited by 118
p53-Dependent and -Independent Functions of the Arf Tumor Suppressor
SHERR, C. J., BERTWISTLE, D., DEN BESTEN, W., KUO, M.-L., SUGIMOTO, M., TAGO, K., WILLIAMS, R. T., ZINDY, F., & ROUSSEL, M. F. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.004 · Cited by 101
“Arf is subject to repression by a variety of other proteins, including Bmi1, Tbx2 and Tbx3, Jun D, Twist, CBX7, and Pokemon (Jacobs et al. 1999b, 2000; Maestro et al. 1999; Weitzman et al. 2000; Lingbeek et al. 2002; Gil et al. 2004; Maeda et al. 2005).”
BackgroundThe Hallmarks of Cancer from a Redox Perspective
Hornsveld, M., & Dansen, T. B. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6580 · Cited by 115
“Second, the FOXO target gene CITED2 can modulate the activity of the p16 INK4A transcriptional repressor BMI1 (108, 132).”
Epstein-Barr virus LMP1 blocks p16INK4a–RB pathway by promoting nuclear export of E2F4/5
Ohtani, N., Brennan, P., Gaubatz, S., Sanij, E., Hertzog, P., Wolvetang, E., Ghysdael, J., Rowe, M., & Hara, E. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302085 · Cited by 104
“Because p16INK4a expression is also regulated by other factors such as bmi-1, JunB, 14–3-3 , and SNF5 (Jacobs et al., 1999; Dellambra et al., 2000; Passegue and Wagner, 2000; Betz et al., 2002), LMP1 may affect these transcription factors as well.”
BackgroundLau, K. W., Tian, Y.-M., Raval, R. R., Ratcliffe, P. J., & Pugh, C. W. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603675 · Cited by 104
“These chimaeric HIF-a sequences were transferred into the retroviral vector pLZRS-IRES-GFP (Jacobs et al, 1999).”
BackgroundMethodInk4‐Arf locus in cancer and aging
Sherr, C. J. (2012) · WIREs Developmental Biology · doi:10.1002/wdev.40 · Cited by 98
Bmi1 regulates memory CD4 T cell survival via repression of the Noxa gene
Yamashita, M., Kuwahara, M., Suzuki, A., Hirahara, K., Shinnaksu, R., Hosokawa, H., Hasegawa, A., Motohashi, S., Iwama, A., & Nakayama, T. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072000 · Cited by 102
Ramirez-Prado, J. S., Latrasse, D., Rodriguez‐Granados, N. Y., Huang, Y., Manza-Mianza, D., Brik‐Chaouche, R., Jaouannet, M., Citerne, S., Bendahmane, A., Hirt, H., et al. (2019) · The Plant Journal · doi:10.1111/tpj.14502 · Cited by 104
Klochendler‐Yeivin, A., Pikarsky, E., & Yaniv, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2661-2674.2006 · Cited by 113
“However, additional regulators of p19ARF have been identified, i.e., both activators (DMP-1, AP1) and transcriptional repressors (Bmi-1, Tbx2, Tbx3, and Twist) (2, 31, 34, 42, 43).”
Jiang, L., Li, J., & Song, L. (2009) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmp040 · Cited by 106
Sasaki, D., Imaizumi, Y., Hasegawa, H., Osaka, A., Tsukasaki, K., Choi, Y. L., Mano, H., Marquez, V. E., Hayashi, T., Yanagihara, K., et al. (2011) · Haematologica · doi:10.3324/haematol.2010.028605 · Cited by 104
“BMI1 is known to down-regulate the expression of p14ARF/p16INK4A and lead to neoplastic transformation.(31) Chromobox 7 (CBX7), a component of the PRC1, is also known to repress the transcription of p14ARF/p16INK4A.”
BackgroundExpression of Bmi-1 is a prognostic marker in bladder cancer
Qin, Z., Yang, J., Ye, Y., Zhang, X., Xu, L.-H., Zhou, F.-J., Han, H., Liu, Z.-W., Song, L.-B., & Zeng, M. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-61 · Cited by 103
“Bmi-1-deficient mouse embryonic fibroblasts (MEF) overexpress INK4a/ ARF locus-encoded genes CDKN2A and p19ARF (mouse homologue of human p14ARF) and undergo premature senescence in culture[28].”
BackgroundSánchez‐Beato, M., Sánchez, E., González‐Carreró, J., Morente, M. M., Díez, A., Sánchez-Verde, L., Martín, M. C., Cigudosa, J. C., Vidal, M., & Piris, M. A. (2006) · Modern Pathology · doi:10.1038/modpathol.3800577 · Cited by 110
“These results provide no evidence in support of the proposed hypothetical rol”
Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3
Yoneda‐Kato, N., Tomoda, K., Umehara, M., Arata, Y., & Kato, J. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600656 · Cited by 103
“Bmi-1 acts as a potent positive regulator of the self-renewal of HSCs by repressing the transcription of the Ink4a/Arf locus that encodes the tumor suppressors p16 and p19Arf (Jacobs et al, 1999; Lessard and Sauvageau, 2003; Park et al, 2003).”
BackgroundSigner, R. A. J., Montecino-Rodriguez, E., Witte, O. N., & Dorshkind, K. (2008) · Genes & Development · doi:10.1101/gad.1715808 · Cited by 102
“A loss of expression of Bmi-1 (in Bmi1 mice), a potent repressor of both p16 and Arf expression, results in a severe decline in B lymphopoiesis (Jacobs et al. 1999; Park et al. 2003).”
Background
Metadata
- Authors
- Jacobs, J. J. L., Kieboom, K., Marino, S., DePinho, R. A., & van Lohuizen, M.
- Affiliations
- The Netherlands Cancer Institute (NL)
- Harvard University (US)
- Venue
- Nature
- Published
- 1999-01
- Volume
- 397
- Issue
- 6715
- Pages
- 164-168
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1481473039
- Cited by
- 1,580
- References
- 30
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 24 · 2023: 29 · 2022: 36 · 2021: 36 · 2020: 42 · 2019: 43 · 2018: 42 · 2017: 53 · 2016: 71 · 2015: 76 · 2014: 76 · 2013: 76 · 2012: 86
- FWCI
- 16.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- BMI1, Polycomb group proteins, p16, p19ARF, cellular senescence, cell proliferation, cell cycle progression, S phase, transcriptional repression, lymphoma, lymphoid cells, neurological deficit, H-Ras, oncogenic transformation, tumor suppressor
- MeSH terms
- Animals, Cell Cycle, Cell Division, Cells, Cultured, Fibroblasts, Gene Expression Regulation, Humans, Nuclear Proteins, Oncogenes, Proteins, Proto-Oncogene Proteins, Repressor Proteins, Genes, Tumor Suppressor, Cellular Senescence, Mice, Knockout, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Protein p14ARF, Mice, Polycomb Repressive Complex 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.